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Summary
Salbutamol pressurised metered-dose inhalers (pMDIs) are
not equipped with dose counters outside the USA. The aim
of this study was to describe a simple reproducible method
for determining the number of doses remaining in a pMDI
based on scale weight. With a laboratory scale, the mean
weight of the canisters was 28.61 ± 0.10 g after priming
and 14.84 ± 0.23 g after 200 puffs. Similar results were
obtained with two common digital scales. We recommend
weighing salbutamol canisters on a common digital scale,
and replacing an old pMDI with a new one when the weight
falls to ≤15 g.
Introduction
Pressurised metered-dose inhalers (pMDIs) are devices
used to administer inhaled medications. Patients with
asthma or chronic obstructive pulmonary disease are often
prescribed pMDIs containing a beta-adrenergic receptor
agonist, such as salbutamol. These pMDIs are not generally
equipped with a dose counter outside of the USA. There-
fore, given the life-saving potential of these pMDIs, dis-
covering that the device is empty when needed is intensely
dangerous. Indeed, 25% of surveyed patients reported hav-
ing attempted to use an empty pMDI during an asthma ex-
acerbation [1].
There are several techniques for estimating the number of
remaining doses in a pMDI; however shaking, spraying,
and flotation are not reliable [1–5]. The flotation technique
(i.e. immersion in water to determine amount of remain-
ing drug) is currently forbidden by the manufacturer
GlaxoSmithKline for two reasons. Firstly, the technique,
which was developed with inhalers that were loaded with
chlorofluorocarbon propellant gas, is not accurate with
newer inhalers that are loaded with a hydrofluoroalcan pro-
pellant. Secondly, immersion in water compromises the im-
permeability of the pMDI valve. Although the manufac-
turer’s instructions tell the user to count every dose, this
expectation is not practical for a drug that is not admin-
istered on a regular basis.
The aim of this work was to describe a simple, reproducible
method for determining the remaining doses in a sal-
butamol pMDI based on the weight of the canister. Accur-
acy of weighing was compared between a laboratory scale
and two common digital scales.
Methods
Sixty salbutamol pMDIs (GlaxoSmithKline) containing
200 doses with ≥5% overfill were bought in six European
countries (10 pMDIs, with two source batches per country),
including France (Ventoline®), Germany (Sultanol®), Italy,
Spain, Switzerland and the United Kingdom (Ventolin®).
A laboratory scale (Mettler Toledo XP204®) was used to
weigh the canisters. Weights were also obtained with a di-
gital kitchen scale used in our hospital (Ohaus CS 5000®)
and one marketed for home use (IKEA Ordning®). Each
new pMDI was primed by releasing two puffs into the
air. The canisters were weighed immediately after 50, 100,
150, 190 and 200 puffs, with a 30-second inter-puff inter-
val. The mean weights of the canisters measured on the
three scales were compared using a simple linear correla-
tion test (Instat, Graphpad).
Results
The mean weights of the salbutamol canisters measured
with each of the three different scales after priming, and
50, 100, 150, 190, and 200 puffs are reported in table 1.
There was a linear correlation between the mean weights
of the canisters measured on the three scales (r = 0.998, p
<0.0001). Based on the results, a practical table was pro-
duced to determine whether pMDIs are empty or close-to-
empty (table 2).
Discussion
Salbutamol pMDIs produced in most countries outside of
the USA are not equipped with a dose counter. The present
study produced a weight-remaining dose correlation that
can be used to determine the number of remaining doses in
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a pMDI. The table was produced primarily to help health-
care workers in hospitals, clinics, and pharmacies assist pa-
tients in assessing how many doses remain in their pMDIs;
however the method could also be used by patients them-
selves at home after thorough instruction.
The limitation of this study is that the results apply spe-
cifically to salbutamol pMDIs made by GlaxoSmithKline
in Europe. Moreover, the manufacturer should warn health
professionals if the formulation or filling of their pMDIs is
changed.
In conclusion, as long as manufacturers neglect to equip all
pMDIs with a dose counter, we recommend that the num-
ber of doses remaining in salbutamol pMDIs being checked
by weighing the pMDIs on a common digital scale. Our
results indicate that the canister should be replaced when
its weight falls to ≤15 g.
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Table 1: Weight of salbutamol canisters (n = 60) in relation to doses remaining across three different scales.
Mean weight (g)
Remaining doses Mettler Toledo XP204
(laboratory scale)
Ohaus CS 5000 (ward scale) Ikea Ordning
(kitchen scale)
200 28.61 ± 0.10 29 29
150 25.16 ± 0.13 25 25
100 21.72 ± 0.17 22 22
50 18.28 ± 0.20 18 18
10 15.54 ± 0.22 16 16
0 14.84 ± 0.23 15 15
Mettler, Ohaus, and Ikea scales rounded weight to nearest 0.01 g, 1 g, and 1 g, respectively.
Table 2: Practical table to determine if the canisters of the salbutamol pressurised metered-dose inhalers are empty.
Does my pressurised metered-dose inhaler still contain salbutamol?
Weight of canister Drug remaining? Remaining doses
29 g Yes, it is full 200
25 g Yes, it is 3/4 full 150
22 g Yes, it is 1/2 full 100
18 g Yes, it is 1/4 full 50
≤15 g No, it is empty 0
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